MHC Tetramer Reagents (IMAGE)
Caption
A new super-stable form of the MHC tetramer reagents, developed by Danish and German researchers, opens a range of new possibilities for improved monitoring and tracking disease relevant T cells in development of personalized cancer immunotherapies.
Credit
DTU
Usage Restrictions
None
License
Licensed content